Formulation Development Co-op (FALL 2026) jobs in United States
cer-icon
Apply on Employer Site
company-logo

MannKind Corporation · 1 day ago

Formulation Development Co-op (FALL 2026)

MannKind Corporation focuses on the development and commercialization of innovative inhaled therapeutic products and devices. They are seeking a highly motivated engineer to join the Formulation Development department to support the formulation and process development of respiratory drug products.

BiotechnologyHealth CarePharmaceutical
check
Growth Opportunities
badNo H1Bnote

Responsibilities

Support development and optimization of engineered particle inhaled dosage forms
Perform physiochemical property characterization of drug product intermediates
Support batch manufacture for development, pre-clinical studies
Design, execute, and interpret experiments to support formulation and process development, with supervision
Document, compile, review, and present data
Handle hazardous materials and chemicals in accordance with MannKind’s safety policies and procedures
Operate and maintain laboratory equipment
Comply with good laboratory practice including maintenance of laboratory notebooks and written procedures
Observe all Company, Health, Safety, and Environmental guidelines

Qualification

Chemical EngineeringBioengineeringPharmaceutical EngineeringLaboratory Equipment OperationPhysicochemical Property CharacterizationMS OfficeTeam CollaborationOral CommunicationWritten CommunicationTime ManagementOrganizational Skills

Required

Pursuing a bachelor's or master's degree in Chemical Engineering, Bioengineering, or Pharmaceutical Engineering, preferably within 1-2 years of graduation
Strong foundation in science and engineering principles
Strong oral and written communication skills
Ability to work effectively in a collaborative team environment
Fluency in MS Office software
Demonstrates eagerness to learn new techniques and procedures
Accuracy in following instructions, generating data, and documenting data and procedures
Support development and optimization of engineered particle inhaled dosage forms
Perform physiochemical property characterization of drug product intermediates
Support batch manufacture for development, pre-clinical studies
Design, execute, and interpret experiments to support formulation and process development, with supervision
Document, compile, review, and present data
Handle hazardous materials and chemicals in accordance with MannKind's safety policies and procedures
Operate and maintain laboratory equipment
Comply with good laboratory practice including maintenance of laboratory notebooks and written procedures
Observe all Company, Health, Safety, and Environmental guidelines
Full-time commitment, Monday to Friday, onsite
Location: Bedford, MA 01730
Fall 2026: July 8 - December 18, 2026
A reliable commute or the intention to find temporary housing before starting the Co-op is required
At this time, we are only able to consider candidates who do not require visa sponsorship, including those with a student visa

Preferred

Prior experience within life sciences, pharmaceuticals, or biotech industries
You possess superior time management and organizational skills
Experience with general laboratory procedures is a plus
You have an intrinsic motivation to continually improve and optimize processes
You take the initiative to identify opportunities for improvement and act on them without needing constant direction
You are open to constructive criticism and use it to improve performance and grow professionally

Company

MannKind Corporation

twittertwittertwitter
company-logo
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions.

Funding

Current Stage
Public Company
Total Funding
$475M
Key Investors
Blackstone GroupDeerfield Capital Management
2025-08-06Post Ipo Debt· $75M
2021-03-02Post Ipo Debt· $200M
2018-12-01Post Ipo Equity· $40M

Leadership Team

leader-logo
Michael Castagna
Chief Executive Officer
linkedin
leader-logo
Christopher Prentiss
Chief Financial Officer
linkedin
Company data provided by crunchbase